Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Selling General And Administration | 27,760 | 31,062 | 27,410 | 24,264 | 1,291 | -- |
| General And Administrative Expense | 12,259 | 15,561 | 11,909 | 19,097 | 1,291 | -- |
| Other Operating Expenses | 26,370 | 28,125 | 28,167 | 4,065 | -- | 8,052 |
| Operating Expense | 54,130 | 59,187 | 55,577 | 28,329 | 1,291 | -- |
| Operating Income | -54,130 | -59,187 | -55,577 | -28,329 | -1,291 | -- |
| EBIT | -54,130 | -59,187 | -55,577 | -28,329 | -1,291 | -- |
| Other Income Expense | -261.00 | 669.00 | -- | -2.6M | 159.00 | 15,213 |
| Other Non Operating Income Expenses | -- | -- | -- | 0.00 | -- | 15,388 |
| Gain On Sale Of Security | -261.00 | 669.00 | -- | -828.00 | 159.00 | -175.00 |
| Pretax Income | -54,391 | -58,518 | -55,577 | -2.6M | -1,132 | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -54,391 | -58,518 | -55,577 | -2.6M | -1,132 | -- |
| Net Income From Continuing Operation Net Minority Interest | -54,391 | -58,518 | -55,577 | -2.6M | -1,132 | -- |
| Net Income Including Noncontrolling Interests | -54,391 | -58,518 | -55,577 | -2.6M | -1,132 | -- |
| Net Income Common Stockholders | -54,391 | -58,518 | -55,577 | -2.6M | -1,132 | -- |
| Net Income | -54,391 | -58,518 | -55,577 | -2.6M | -1,132 | -- |
| EBITDA | -54,130 | -59,187 | -55,577 | -28,329 | -1,291 | -- |
| Normalized EBITDA | -53,869 | -59,856 | -55,577 | 2.6M | -1,450 | -- |
| Basic EPS | 0.00 | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Diluted EPS | 0.00 | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Basic Average Shares | 63.6M | 63.1M | 61.9M | -- | 61.9M | 61.9M |
| Diluted Average Shares | 63.6M | 63.1M | 61.9M | -- | 61.9M | 61.9M |
| Total Unusual Items | -261.00 | 669.00 | -- | -2.6M | 159.00 | -175.00 |
| Total Unusual Items Excluding Goodwill | -261.00 | 669.00 | -- | -2.6M | 159.00 | -175.00 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Normalized Income | -54,130 | -59,187 | -55,577 | -28,329 | -1,291 | -- |
| Diluted NI Availto Com Stockholders | -54,391 | -58,518 | -55,577 | -2.6M | -1,132 | -- |
| Net Income Continuous Operations | -54,391 | -58,518 | -55,577 | -2.6M | -1,132 | -- |
| Other Gand A | 12,259 | 15,561 | 11,909 | 19,097 | 1,291 | -- |
| Rent And Landing Fees | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Rent Expense Supplemental | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Selling And Marketing Expense | 15,501 | 15,501 | 15,501 | 5,167 | 0.00 | -- |
| Total Expenses | 54,130 | 59,187 | 55,577 | 28,329 | 1,291 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 5,927 | 1,097 | 2,140 | 3,499 | 3,308 | -- |
| Cash Cash Equivalents And Short Term Investments | 5,927 | 1,097 | 2,140 | 3,499 | 3,308 | -- |
| Cash Financial | 5,927 | 1,097 | 2,140 | 3,499 | 3,308 | -- |
| Prepaid Assets | 13,830 | 29,331 | 41,332 | 56,833 | -- | -- |
| Current Assets | 19,757 | 30,428 | 43,472 | 60,332 | 3,308 | -- |
| Net PPE | 22,876 | -- | -- | 0.00 | 2.6M | 2.6M |
| Total Non Current Assets | 22,876 | 0.00 | 0.00 | 0.00 | 2.6M | -- |
| Total Assets | 42,633 | 30,428 | 43,472 | 60,332 | 2.6M | -- |
| Accounts Payable | 73,705 | 141,974 | 157,500 | 118,783 | 107,602 | -- |
| Payables | 248,330 | 186,974 | 157,500 | 118,783 | 107,602 | -- |
| Payables And Accrued Expenses | 248,330 | 186,974 | 157,500 | 118,783 | 107,602 | -- |
| Current Liabilities | 248,330 | 186,974 | 157,500 | 118,783 | 107,602 | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 248,330 | 186,974 | 157,500 | 118,783 | 107,602 | -- |
| Common Stock | 6.3M | 6.3M | 6.3M | 6.3M | 6.3M | -- |
| Capital Stock | 6.3M | 6.3M | 6.3M | 6.3M | 6.3M | -- |
| Retained Earnings | -7.4M | -7.3M | -7.3M | -7.2M | -4.6M | -- |
| Gains Losses Not Affecting Retained Earnings | 878,970 | 878,970 | 836,470 | 836,470 | 836,470 | -- |
| Other Equity Adjustments | 878,970 | 878,970 | 836,470 | 836,470 | 836,470 | -- |
| Common Stock Equity | -205,697 | -156,546 | -114,028 | -58,451 | 2.5M | -- |
| Stockholders Equity | -205,697 | -156,546 | -114,028 | -58,451 | 2.5M | -- |
| Total Equity Gross Minority Interest | -205,697 | -156,546 | -114,028 | -58,451 | 2.5M | -- |
| Total Capitalization | -205,697 | -156,546 | -114,028 | -58,451 | 2.5M | -- |
| Net Tangible Assets | -205,697 | -156,546 | -114,028 | -58,451 | 2.5M | -- |
| Tangible Book Value | -205,697 | -156,546 | -114,028 | -58,451 | 2.5M | -- |
| Working Capital | -228,573 | -156,546 | -114,028 | -58,451 | -104,294 | -- |
| Invested Capital | -205,697 | -156,546 | -114,028 | -58,451 | 2.5M | -- |
| Share Issued | 63.6M | 63.6M | 61.9M | 61.9M | 61.9M | -- |
| Ordinary Shares Number | 63.6M | 63.6M | 61.9M | 61.9M | 61.9M | -- |
| Dueto Related Parties Current | 174,625 | 45,000 | -- | -- | -- | -- |
| Other Equity Interest | 11,240 | 6,000 | 75,000 | 75,000 | -- | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -410.00 | -7,043 | -1,359 | -74,809 | -378.00 | -- |
| Cash Flow From Continuing Operating Activities | -410.00 | -7,043 | -1,359 | -74,809 | -378.00 | -- |
| Change In Working Capital | 53,981 | 51,475 | 54,218 | -45,652 | 754.00 | -- |
| Changes In Account Receivables | -- | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Change In Receivables | -- | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Change In Payables And Accrued Expense | 38,480 | 39,474 | 38,717 | 11,181 | 754.00 | -- |
| Change In Payable | 38,480 | 39,474 | 38,717 | 11,181 | 754.00 | -- |
| Purchase Of PPE | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Net PPE Purchase And Sale | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Investing Cash Flow | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash Flow From Continuing Investing Activities | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance Of Capital Stock | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Net Common Stock Issuance | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | 5,240 | -- | -- | 75,000 | 0.00 | 0.00 |
| Cash Flow From Continuing Financing Activities | 5,240 | -- | -- | 75,000 | 0.00 | 0.00 |
| Changes In Cash | 4,830 | -1,043 | -1,359 | 191.00 | -378.00 | -- |
| Beginning Cash Position | 1,097 | 2,140 | 3,499 | 3,308 | 3,686 | -- |
| End Cash Position | 5,927 | 1,097 | 2,140 | 3,499 | 3,308 | -- |
| Free Cash Flow | -410.00 | -7,043 | -1,359 | -74,809 | -378.00 | -- |
| Change In Prepaid Assets | 15,501 | 12,001 | 15,501 | -56,833 | 0.00 | -- |
| Common Stock Issuance | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -54,391 | -58,518 | -55,577 | -2.6M | -1,132 | -- |